NURS 571 FINAL CARE OF THE LGBTQ+ PATIENT
Transgender Woman Goals - Answers - Stimulate development of female secondary
sex characteristics are goals of
Transgender Woman Treatment - Answers - estrogen, antiandrogens, gonadotropin-
releasing hormone (GnRH) agonists, or others is the treatment
Transgender Woman Monitoring needs - Answers - Estradiol, Testosterone, Prolactin,
Triglycerides
Potassium if spironolactone used as antiandrogen this we monitor in
Transgender Woman Risks - Answers - Thromboembolic events (small risk) are risk
Transgender Man Goals - Answers - Stop menstruation, Stimulate development of
male secondary sex characteristics are goal of
Transgender Man Treatment - Answers - testosterone as would be done in
hypogonadism is the treatment for
Transgender Man Monitoring needs - Answers - Serum testosterone levels every 3
months until optimal, then 1-2 times a year, Hematocrit, Hemoglobin, Serum cholesterol
needs to be monitored for
Transgender Man risk - Answers - Acne Possible, male-pattern hair loss, Polycythemia
Hypercholesterolemia, Liver impairment, Thromboembolic disorders with increased risk
of myocardial infarction and stroke are risk for
elderly - Answers - Added stress, Inconvenience, Feeling tied to the regimen are
impacts on quality of life for
nitrate-free interval - Answers - Tolerance can occur when there are no
To prevent GI upset - Answers - why medications be taken with food
Contin and Zine - Answers - considerations related to Beer's Criteria what meds
Statin and Contin - Answers - ? should be administered at least 2 hour before or after
?
Nitrate - Answers - should not be taken after 4 pm to ensure a nitrate free interval what
med
Dronate - Answers - should be taken 30 minutes before eating with a full 8-ounce
glass of water. Do not lie down for 30 minutes after taking this medication what is it
, Pharmacokinetic Interactions - Answers - when one medication systemically alters the
potency of another medication.
Absorption Interaction - Answers - result of a change due to one medication's effect on
another medication's route of entry into the body.
Distribution Interaction - Answers - caused by the amount of unbound/free medications
available at the various target sites.
Metabolism Interaction - Answers - concentration of the medication after
biotransformation into active and inactive metabolites in higher or lower than expected.
Elimination Interaction - Answers - the body's ability to eliminate medications in pure
form or by altering a metabolite from the body.
Pharmacodynamic Interactions - Answers - does not alter or impact absorption,
distribution, metabolism, or elimination because of the one medication's ability to
manipulate the effect of another medication at its site of action.
Distribution - Answers - Warfarin (Coumadin) being sensitive to protein-bound
displacement is an example of a(n) _________ interaction.
Elimination - Answers - Litium (Lithobid) unchanged medication concentration is
increased due to the amount of sodium concentration. This is a key contributor to a(n)
___________ interaction.
Challenges the providers - Answers - Lack of familiarity with gender modification
surgeries
Failure to use gender-neutral terms such as significant other, partner, personal
pronouns, Lack of sensitivity when addressing sexual practices unique to the LGBTQ+
community, Lack of understanding of cultural behavior
Patient distrust in the medical system or prior traumatic experience with healthcare
providers, Lack of sensitivity toward individuals that may engage in relationships with
multiple partners are challenges for
Challenges that LGBTQ+ patients - Answers - Use of excessive precautions or refusal
to touch them
Blame for their sexual preference or health status
Use of harsh or abusive language, Harassment by providers or other patients in a
healthcare setting, Denial of medical services are challenges for
common challenge by both - Answers - lack of understanding regarding the acceptable
use of terminology is a challenge for
independent characteristics. - Answers - sexual orientation AND a gender identity
which are
Transgender Woman Goals - Answers - Stimulate development of female secondary
sex characteristics are goals of
Transgender Woman Treatment - Answers - estrogen, antiandrogens, gonadotropin-
releasing hormone (GnRH) agonists, or others is the treatment
Transgender Woman Monitoring needs - Answers - Estradiol, Testosterone, Prolactin,
Triglycerides
Potassium if spironolactone used as antiandrogen this we monitor in
Transgender Woman Risks - Answers - Thromboembolic events (small risk) are risk
Transgender Man Goals - Answers - Stop menstruation, Stimulate development of
male secondary sex characteristics are goal of
Transgender Man Treatment - Answers - testosterone as would be done in
hypogonadism is the treatment for
Transgender Man Monitoring needs - Answers - Serum testosterone levels every 3
months until optimal, then 1-2 times a year, Hematocrit, Hemoglobin, Serum cholesterol
needs to be monitored for
Transgender Man risk - Answers - Acne Possible, male-pattern hair loss, Polycythemia
Hypercholesterolemia, Liver impairment, Thromboembolic disorders with increased risk
of myocardial infarction and stroke are risk for
elderly - Answers - Added stress, Inconvenience, Feeling tied to the regimen are
impacts on quality of life for
nitrate-free interval - Answers - Tolerance can occur when there are no
To prevent GI upset - Answers - why medications be taken with food
Contin and Zine - Answers - considerations related to Beer's Criteria what meds
Statin and Contin - Answers - ? should be administered at least 2 hour before or after
?
Nitrate - Answers - should not be taken after 4 pm to ensure a nitrate free interval what
med
Dronate - Answers - should be taken 30 minutes before eating with a full 8-ounce
glass of water. Do not lie down for 30 minutes after taking this medication what is it
, Pharmacokinetic Interactions - Answers - when one medication systemically alters the
potency of another medication.
Absorption Interaction - Answers - result of a change due to one medication's effect on
another medication's route of entry into the body.
Distribution Interaction - Answers - caused by the amount of unbound/free medications
available at the various target sites.
Metabolism Interaction - Answers - concentration of the medication after
biotransformation into active and inactive metabolites in higher or lower than expected.
Elimination Interaction - Answers - the body's ability to eliminate medications in pure
form or by altering a metabolite from the body.
Pharmacodynamic Interactions - Answers - does not alter or impact absorption,
distribution, metabolism, or elimination because of the one medication's ability to
manipulate the effect of another medication at its site of action.
Distribution - Answers - Warfarin (Coumadin) being sensitive to protein-bound
displacement is an example of a(n) _________ interaction.
Elimination - Answers - Litium (Lithobid) unchanged medication concentration is
increased due to the amount of sodium concentration. This is a key contributor to a(n)
___________ interaction.
Challenges the providers - Answers - Lack of familiarity with gender modification
surgeries
Failure to use gender-neutral terms such as significant other, partner, personal
pronouns, Lack of sensitivity when addressing sexual practices unique to the LGBTQ+
community, Lack of understanding of cultural behavior
Patient distrust in the medical system or prior traumatic experience with healthcare
providers, Lack of sensitivity toward individuals that may engage in relationships with
multiple partners are challenges for
Challenges that LGBTQ+ patients - Answers - Use of excessive precautions or refusal
to touch them
Blame for their sexual preference or health status
Use of harsh or abusive language, Harassment by providers or other patients in a
healthcare setting, Denial of medical services are challenges for
common challenge by both - Answers - lack of understanding regarding the acceptable
use of terminology is a challenge for
independent characteristics. - Answers - sexual orientation AND a gender identity
which are
